Notably, excessive CaMKII activation is associated with arrhythmias and cardiac remodeling, suggesting the Piezo1-CaMKII axis as a potential therapeutic target for cardiovascular diseases. The gene discussed is CAMK2G; the disease is cardiac arrhythmia.